In Europe on Tuesday, the FTSE Eurofirst 300 added 0.98 percent to 1,460.47. Other European exchanges saw similar gains, with the Xetra Dax in Frankfurt gaining 0.92 percent to 6,595 and the CAC 40 up 0.97 percent to 5,437.13 in Paris.

The pharmaceutical sector was higher after Novartis (NYSE: NVS) gained approval from the US Food and Drug Administration for Tektura, a new blood pressure treatment that could generate as much as $1 billion per year in sales by 2010. Novartis added 4.9 percent to SFr70.10. Helped by this success and by analyst comment that pharma shares are too cheap, Merck (NYSE: MRK) gained 0.8 percent to €92.70 and Roche (SWX: ROG; OTC: RHHBY) was 0.9 percent higher to SFr216.

Peugeot’s (Euronext: UG; OTC: PEUGY) chief executive said at the opening of the Geneva car show that his company is not interested in purchasing DaimlerChrysler’s (FWB: DCX; NYSE: DCX; TYO: 7663) US Chrysler division. With no rivals voicing interest, analysts believe that any offers for the troubled carmaker will likely come from private equity and, indeed, rumors have a couple of private entities interested. Peugeot added 0.7 percent to €49.43, while DaimlerChrysler was 3 percent higher to €52. Meanwhile, Fiat (NYSE: FIA) gained 0.6 percent to €17.67 after Goldman Sachs repeated its “conviction buy” on the carmaker and raised its target share price from €17 to €22.

The FTSE Eurofirst 300 was lower on Thursday, losing early gains after the New York markets were weaker in early trade. The 300 closed at 1,509.47, a decline of 0.1 percent on the session.

The pharmaceuticals sector saw declines. Novartis dropped 1.4 percent to SFr72.60 even though it reported record sales and profits in its full-year results when its outlook for the new year didn’t please investors. Merck, meanwhile, was 1.9 percent lower to €88.04 even though it said its operating profits were up by 58 percent in the fourth quarter.

Allianz dropped 1.9 percent to €151.68 on its offer to buy the 42.2 percent of French insurer AGF that it does not already own. The deal, which had been expected, involves €7.5 billion in cash and €2.3 billion in shares. Some shareholders would have preferred that the German insurer buy back its own shares. AGF added 0.2 percent to € on the news.

In the telecommunications sector, KPN gained 2.7 percent to €11.67 when Goldman Sachs put the Dutch company on its European buy list.

Endemol added 0.2 percent to €19.22 after JP Morgan said that Telefonica will soon sell its 75 percent stake in the Dutch television production company. Some analysts said that the share price could be driven higher than it might have otherwise been due to increased ratings for Endemol’s “Big Brother” reality show. The higher ratings have been generated by recent controversy over the show.

In slow trading due to the Martin Luther King Jr. holiday in the United States, the FTSE Eurofirst 300 nonetheless gained 0.6 percent on the session to close at 1,520.04.

The oil sector was higher even though crude oil prices remained low. OMV added 0.5 percent to €39.38 despite a UBS target share price downgrade from €45 to €43. Repsol gained 0.7 percent to €25.40, while Neste Oil was 2.5 percent higher to €23.07. Even bigger gains were achieved by Norsk Hydro and Statoil, proposed merger partners. Norsk was up 3.2 percent to NKr188.25, while Statoil added 4 percent to NKr162.

In the aerospace sector, EADS gained 2.7 percent to €25.75 on the news that its Eurocopter unit had won a contract to build 37 helicopters for the French police. Engine makers for airplanes, however, were mixed. MTU Aero Engines added 3.2 percent to €37.16 as Deutsche Bank reiterated its “buy” recommendation on the German manufacturer. However, Deutsche Bank reduced its recommendation for French engine maker Safran from “hold” to “sell” on earnings issues. Safran dropped 1 percent, to €17.20.

Merck added 1.8 percent to €89.04 on a raised price target and reconfirmed “overweight” rating from Lehman Brothers. The German pharmaceuticals company, which offered last week for the 16 percent of Serono that it does not yet hold, added 1.8 percent to €89.04.

Despite a series of rumors relating to mergers & acquisitions in several sectors this week, the European equities markets were lower on Friday and for the week as investors became concerned again about the state of the US economy, which seems to be slowing. The FTSE Eurofirst 300 was 1.1 percent lower on Friday to 1,370.86, bringing it to an 0.2 percent decline for the week even though it hit four-month highs earlier in the week.

One sector that saw activity on the M&A front was pharmaceuticals. German company Merck announced that it will purchase Serono to create the seventh largest pharma group in Europe. The deal will cost Merck €10.6 billion. Merck gained 1.2 percent over the week to €76.90, while Serono added 21.8 percent to SFr1,076. Elsewhere in the sector, Altana added 0.2 percent to €45.31 on the news that it will sell its pharmaceutical unit to Nycomed.

Continental added 2.7 percent to €88.36 after it said that had been approached about a deal. The gain came even though discussions had ended after analysts expressed the opinion that the German tire maker is a good target for a leveraged buyout.

Swedish truck maker Scania B shares gained 6.5 percent to €452 after it rejected an offer from MAN. MAN dropped 1.9 percent to €62.77 on the news, but the two biggest shareholders in Scania saw gains out of the issue. Volkswagen added 0.4 percent to €65.23 and Investor was 1.6 percent higher to SKr155.50.

The FTSE Eurofirst 300 was 0.4 percent higher on Thursday, to 1,386.58 as mergers and acquisitions activity, both agreed to and rumored, again was in the spotlight.

The news that Merck will buy a 64.5 percent stake in Serono mobilized the pharmaceuticals sector. Merck, which will spend SFr16.6 billion in the deal, dropped 4.7 percent on the session to €74.65. Serono, however, added 17.6 percent to SFr1,076 on the announcement of the deal. Elsewhere in the sector, Altana gained 1.2 percent to €45.17 after it said it will sell its pharmaceuticals business to Danish company Nycomed. In addition, Sanofi-Aventis was 1.4 percent higher to €69.65.

Bids rumors led to gains in the Swiss specialty chemical sector. On the strength of a rumor that Dow Chemical is thinking of bidding, Ciba gained 2.9 percent to SFr73.60, while Clariant added 3.7 percent to SFr16.90 amid speculation of interest from private equity.

EADS was 2.4 percent lower to €22.26 after it announced yet another delay in delivery of the A380 superjumbo jet. Not all the news for EADS was bad, however, as Lufthansa said it has put in an order for 30 Airbus A320s, a smaller aircraft, and has the option to order an additional 30 planes.

The Norwegian oil sector was lower on recent declines in crude oil prices. Statoil dropped 3.2 percent to NKr155, while Norsk Hydro fell 4 percent to NKr145.

The FTSE Eurofirst 300 was down for the day on Friday as well as lower for the week as a whole. The 300 lost 0.6 percent on the day to 1,260.8, a loss of 1.2 percent during the week as investors seemed to ignore positive economic data.

In the telecommunications sector, Telefonica declined by 1.6 percent to €12.79, while TeliaSonera dropped 10.9 percent to SKr40.00 after it made public plans to enter the Spanish mobile phone market.

Aircraft manufacturer EADS lost 24.7 percent to €20.00 after it said it would lose €2 billion in profits in the next four years due to delays in delivery of the new Airbus A380 superjumbo jet. Further hurting the company, some executives had to admit mistakes in selling shares just weeks before the delays were made known to the public.

In the banking sector, Credit Agricole added 0.1 percent to €28.02 after offering for Greek bank Emporiki, which added 12.2 percent to €26.30 on news of the bid.

Pharmaceuticals were mixed. Bayer added 0.6 percent to €33.31 after it triumphed over Merck in a bidding battle for Schering and received an upgrade from “hold” to “add” from WestLB. Merck dropped 0.2 percent to €73.80, while Schering was up 3.4 percent to €89.14.

European equities did a bit better on Wednesday, despite new data on prices out of the US that only served to heighten worries that inflation is getting out of hand. The FTSE Eurofirst 300 was up 0.1 percent by the end of the trading day to 1,240.15.

Banking and finance was mixed on mergers and acquisitions issues. After Credit Suisse said that it would sell its Winterthur insurance business to French insurer Axa, Credit Suisse gained 1.4 percent to SFr63.70 but Axa dropped 1.8 percent to €23.87. Meanwhile, Greek bank Emporiki added 1.8 percent to €25.24 as investors hoped for another bid after Greece’s finance minister made the comment that it should not be too quick to accept Credit Agricole’s bid. Agricole, meanwhile, was up 2.1 percent to €27.33.

The pharmaceuticals sector also saw maneuvering around bids issues. Bayer added 6.9 percent to €32.66 when competitor Merck took itself out of the bidding for German healthcare group Schering. Schering gained 2.1 percent to €89.00, while Merck was up 6 percent to €72.58 as investors anticipated a possible special dividend.

On the negative side of the ledger, airplane manufacturer EADS lost 26.3 percent to €18.73 after announcing that delays in deliveries of the Airbus A380 superjumbo jet would cost it €2 billion next year and that in view of the delays, it would allow buyers to walk away from orders they had already placed. In consequence, Deutsche Bank issued a downgrade on EADS from “buy” to “hold” and revised its target share price downward from €33 to €26. WestLB, on the other hand, upgraded the aircraft maker to “buy”.

In Europe on Friday, the FTSE Eurofirst 300 was up 0.5 percent to 1,383.19. The day’s gain helped the Eurofirst to add 1 percent on the week.

In the pharmaceuticals sector, Schering was up 4.6 percent on the week to €86.30 on an offer from Bayer that was higher than an earlier bid from Merck, which withdrew its bid on the grounds that it could not justify upping its offer. Even though WestLB issued a downgrade on Bayer from “add” to “hold” because it considered the possible deal “ambitious”, Bayer still added 6.8 percent on the week to €35.42. Merck, meanwhile, gained 1.4 percent to €80.99 on a reiteration of WestLB’s “buy” recommendation. Elsewhere in the sector, Sanofi-Aventis was up by 5.2 percent to €77.45 on news that a patent dispute had been settled.

In the automobile manufacturing sector, Volkswagen gained 6.7 percent to €62.13, while Fiat was up 7.6 percent to €10.01. BMW added 8.8 percent to €46.01 on indications that it will do well this year.

French telecom equipment maker Alcatel gained 1.6 percent to €13.05 on Friday, a two-year high, bringing its advance for the week to 8.9 percent. The gains came on news that it had re-entered merger talks with US company Lucent Technologies. Rumors that a merger would prompt Alcatel to sell its 9.5 percent stake in defense group Thales. This sent shares in Thales up 4.5 percent on Friday, to €37.65.

The FTSE Eurofirst 300 was up 0.1 percent on Friday and gained 1.1 percent over the week to close at 1,369.38. Mergers and acquisitions provided most of the activity during the week.

Doubts that a widely-touted merger between Deutsche Borse and Euronext would come to anything did not hurt the shares of either stock market operator. Deutsche Borse was up 13.2 percent over the week, ending at €117.74, while Euronext was up 15.5 percent to €63.50. Some analysts said that such a merger would face a number of problems, including a monopoly on the derivatives market but not least where the headquarters of the newly created company would be located.

Analysts also had questions about a rumor that Zurich Financial Services is in discussions with US company St. Paul Travelers concerning a merger. Despite the questions, ZFS was up 4.7 percent on the day and gained 5.4 percent over the week to close at SFr316 on Friday.

In the pharmaceuticals sector, Schering was up and Merck was down over the week after Schering rejected an offer worth €77 per share from Merck. Merck dropped 4.6 percent to €79.90, while Schering gained 24 percent to €82.85.

In the automobile manufacturing sector, BMW was up 4.3 percent to €42.30 after it issued a positive guidance report that prompted a number of brokers to upgrade the carmaker’s shares.